AVITA Medical, Inc. (RCEL) Social Stream
AVITA MEDICAL INC (RCEL) Price Targets From Analysts
Use the tables below to see what analysts covering AVITA MEDICAL INC think about its future price and what recommendations they have for investors and traders.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 3 | $45 | $23 | $34 | $12.61 | 169.63% |
| 2022-02-28 | 3 | $34 | $23 | $27.333 | $12.61 | 116.76% |
| 2022-03-02 | 3 | $25 | $15 | $19.333 | $12.61 | 53.31% |
| 2022-05-16 | 3 | $25 | $11 | $17 | $12.61 | 34.81% |
| 2022-11-15 | 3 | $25 | $11 | $16.033 | $12.61 | 27.15% |
| 2022-11-27 | 3 | $25 | $11 | $16.266 | $12.61 | 28.99% |
| 2023-02-08 | 3 | $17.5 | $11 | $13.766 | $12.61 | 9.17% |
| 2023-02-23 | 3 | $17.5 | $12.8 | $15.433 | $12.61 | 22.39% |
| 2023-02-27 | 4 | $17.5 | $15 | $16.166 | $12.61 | 28.2% |
| 2023-04-17 | 4 | $19 | $15 | $16.875 | $12.61 | 33.82% |
| 2023-05-11 | 4 | $19 | $17.5 | $18.25 | $12.61 | 44.73% |
| 2023-05-15 | 4 | $20 | $18 | $18.875 | $12.61 | 49.68% |
| 2023-06-20 | 4 | $26 | $18 | $20.625 | $12.61 | 63.56% |
| 2023-06-27 | 5 | $26 | $18 | $21.1 | $12.61 | 67.33% |
| 2023-07-13 | 6 | $40 | $18 | $24.25 | $12.61 | 92.31% |
| 2023-07-28 | 6 | $40 | $18.5 | $25.75 | $12.61 | 104.2% |
| 2023-09-04 | 6 | $40 | $23 | $27.833 | $12.61 | 120.72% |
| 2023-10-19 | 6 | $40 | $23 | $27.166 | $12.61 | 115.43% |
| 2023-11-13 | 6 | $40 | $19 | $26.5 | $12.61 | 110.15% |
| 2023-11-20 | 6 | $40 | $19 | $24.5 | $12.61 | 94.29% |
The Trend in the Analyst Price Target
RCEL's average price target has moved up $8.47 over the prior 16 months.
Over the past 43 weeks, RCEL's average upside potential has been 57.58%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-02-27 | 3 | 17.5 | 15 | 16.166 | 13.17 | 22.75% |
| 2023-05-15 | 4 | 20.0 | 18 | 18.875 | 12.64 | 49.33% |
| 2023-06-27 | 6 | 26.0 | 18 | 21.100 | 15.66 | 34.74% |
| 2023-11-13 | 6 | 40.0 | 19 | 24.500 | 12.50 | 96% |
| 2023-11-13 | 6 | 40.0 | 19 | 26.500 | 12.50 | 112% |
RCEL Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
Over the past 123 days, RCEL's average broker recommendation rating improved by 0.
The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for RCEL as an investment opportunity.
- In terms of how AVITA MEDICAL INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 374.56% of that group.
- AVITA MEDICAL INC's variance in analysts' estimates is lower than -1178.59% of all US stocks.
- In the context of Medical Equipment stocks, AVITA MEDICAL INC's average analyst price target is higher than 628.49% of them.
- In the context of Medical Equipment stocks, AVITA MEDICAL INC's upside potential (average analyst target price relative to current price) is higher than 1209.02% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Medical Equipment industry with the ratings most similar to AVITA MEDICAL INC are XAIR, LQDA, and CTSO.
View All Top Stocks by Price Target
Is RCEL a Buy, Hold or Sell? See the POWR Ratings now!